{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:08:57Z","timestamp":1791864537310,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Foundation NPO"},{"name":"Italian Ministry for Education","award":["PRIN20153NBRS3_003"],"award-info":[{"award-number":["PRIN20153NBRS3_003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.expneurol.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T05:02:35Z","timestamp":1537419755000},"page":"88-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-806X","authenticated-orcid":false,"given":"Tommaso","family":"Cassano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Magini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giovagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Polchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Calcagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Angelo","family":"Lavecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosanna","family":"Bronzuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Gentileschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Gaetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Emiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Dolcetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.expneurol.2018.09.011_bb0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9440(10)63687-5","article-title":"Up-regulation of phosphorylated\/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease","volume":"163","author":"An","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2018.09.011_bb0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2015.09.005","article-title":"Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's syndrome","volume":"82","author":"Andrade-Talavera","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"3 Suppl","key":"10.1016\/j.expneurol.2018.09.011_bb0015","first-page":"213","article-title":"Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections","volume":"107","author":"Arnell","year":"2007","journal-title":"J. Neurosurg."},{"issue":"10","key":"10.1016\/j.expneurol.2018.09.011_bb0020","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/npp.2010.80","article-title":"Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus","volume":"35","author":"Bambico","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.freeradbiomed.2015.12.012","article-title":"Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: a new paradigm","volume":"91","author":"Barone","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2018.09.011_bb0030","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-018-1231-5","article-title":"Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease","author":"Barone","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.expneurol.2018.09.011_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JAD-131910","article-title":"Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease","volume":"40","author":"Bedse","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.expneurol.2018.09.011_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-160942","article-title":"Alterations of clock gene RNA expression in brain regions of a triple transgenic model of Alzheimer's disease","volume":"59","author":"Bellanti","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"17","key":"10.1016\/j.expneurol.2018.09.011_bb0045","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.expneurol.2018.09.011_bb0050","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1074\/jbc.M110.180638","article-title":"Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism","volume":"286","author":"Caccamo","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.expneurol.2018.09.011_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbr.2011.06.029","article-title":"Olfactory memory is impaired in a triple transgenic model of Alzheimer disease","volume":"224","author":"Cassano","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.expneurol.2018.09.011_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.09.021","article-title":"Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease","volume":"33","author":"Cassano","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.expneurol.2018.09.011_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0091-3057(94)00331-9","article-title":"Behavioral effects of vehicles: DMSO, ethanol, Tween-20, Tween-80, and emulphor-620","volume":"50","author":"Castro","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6815","key":"10.1016\/j.expneurol.2018.09.011_bb0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/35050103","article-title":"A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease","volume":"408","author":"Chen","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2018.09.011_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.phrs.2008.04.004","article-title":"New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation","volume":"57","author":"Colucci","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.expneurol.2018.09.011_bb0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.expneurol.2018.09.011_bb0085","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/db07-0922","article-title":"mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes","volume":"57","author":"Fraenkel","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0090","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"issue":"1","key":"10.1016\/j.expneurol.2018.09.011_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12028-015-0224-8","article-title":"The Insertion and Management of External Ventricular Drains: an Evidence-Based Consensus Statement: a Statement for Healthcare Professionals from the Neurocritical Care Society","volume":"24","author":"Fried","year":"2016","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.expneurol.2018.09.011_bb0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jchromb.2015.01.035","article-title":"Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard","volume":"985","author":"Giovagnoli","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2018.09.011_bb0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0006-8993(99)01832-6","article-title":"Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring","volume":"844","author":"Giustino","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2018.09.011_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2012.06.054","article-title":"Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice","volume":"223","author":"Halloran","year":"2012","journal-title":"Neuroscience"},{"issue":"7253","key":"10.1016\/j.expneurol.2018.09.011_bb0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.expneurol.2018.09.011_bb0120","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.18632\/oncotarget.2337","article-title":"Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors","volume":"5","author":"Hassan","year":"2014","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.expneurol.2018.09.011_bb0125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/NEN.0000000000000083","article-title":"mTOR Hyperactivation in down syndrome hippocampus appears early during development","volume":"73","author":"Iyer","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2018.09.011_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2012.05.003","article-title":"Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells","volume":"324","author":"Juengel","year":"2012","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.expneurol.2018.09.011_bb0135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0091-3057(82)90053-3","article-title":"Animal model of depression: pharmacological sensitivity of a hedonic deficit","volume":"16","author":"Katz","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.expneurol.2018.09.011_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2018.09.011_bb0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.1975.tb25349.x","article-title":"Biological effects of the metabolites of dimethyl sulfoxide","volume":"243","author":"Kocsis","year":"1975","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.expneurol.2018.09.011_bb0150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrneurol.2013.83","article-title":"Diagnosis and treatment of primary CNS lymphoma","volume":"9","author":"Korfel","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"19","key":"10.1016\/j.expneurol.2018.09.011_bb0155","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.expneurol.2018.09.011_bb0160","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1111\/bph.13626","article-title":"Continuous administration of the mTORC1 inhibitor everolimus induces tolerance and decreases autophagy in mice","volume":"173","author":"Kurdi","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.expneurol.2018.09.011_bb0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1172\/JCI64099","article-title":"Rapalogs and mTOR inhibitors as anti-aging therapeutics","volume":"123","author":"Lamming","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.expneurol.2018.09.011_bb0170","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.transproceed.2009.08.050","article-title":"Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement","volume":"41","author":"Lang","year":"2009","journal-title":"Transplant. Proc."},{"issue":"9","key":"10.1016\/j.expneurol.2018.09.011_bb0175","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease","volume":"33","author":"Lin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.expneurol.2018.09.011_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0271678X15621575","article-title":"Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease","volume":"37","author":"Lin","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"14","key":"10.1016\/j.expneurol.2018.09.011_bb0185","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1158\/1078-0432.CCR-06-2770","article-title":"RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model","volume":"13","author":"Mabuchi","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.expneurol.2018.09.011_bb0190","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1093\/hmg\/ddx214","article-title":"TFEB activation restores migration ability to Tsc1-deficient adult neural stem\/progenitor cells","volume":"26","author":"Magini","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.expneurol.2018.09.011_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.expneurol.2018.09.011_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","article-title":"Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1\u03b2 and enhancing NMDA signaling","volume":"11","author":"Majumder","year":"2012","journal-title":"Aging Cell"},{"issue":"9","key":"10.1016\/j.expneurol.2018.09.011_bb0205","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/13803395.2011.595396","article-title":"Effects of immunosuppressive drugs on the cognitive functioning of renal transplant recipients: a pilot study","volume":"33","author":"Mart\u00ednez-Sanchis","year":"2011","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"3","key":"10.1016\/j.expneurol.2018.09.011_bb0210","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1091\/mbc.e03-09-0704","article-title":"In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker","volume":"15","author":"Mizushima","year":"2003","journal-title":"Mol. Biol. Cell"},{"issue":"9637","key":"10.1016\/j.expneurol.2018.09.011_bb0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"RECORD-1 Study Group. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2007.09.019","article-title":"Prevention of atherosclerosis by the mtor inhibitor everolimus in ldlr\u2212\/\u2212mice despite severe hypercholesterolemia","volume":"198","author":"Muller","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.expneurol.2018.09.011_bb0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrn1385","article-title":"NMDA receptors, place cells and hippocampal spatial memory","volume":"5","author":"Nakazawa","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2018.09.011_bb0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.expneurol.2018.09.011_bb0235","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00280-009-1068-8","article-title":"Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents","volume":"65","author":"O'Reilly","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2018.09.011_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11060-014-1531-1","article-title":"Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients","volume":"120","author":"Peyrl","year":"2014","journal-title":"J. Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.expneurol.2018.09.011_bb0245","first-page":"87","article-title":"Rapamycin loaded solid lipid nanoparticles as a new tool to deliver mTOR inhibitors: formulation and in vitro characterization","volume":"6","author":"Polchi","year":"2016","journal-title":"Nano"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0250","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression - new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0255","doi-asserted-by":"crossref","unstructured":"Powers, R.W. 3rd, Kaeberlein, M., Caldwell, S.D., Kennedy, B.K., Fields, S., 2006. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20(2): 174\u201384. doi: https:\/\/doi.org\/10.1101\/gad.1381406.","DOI":"10.1101\/gad.1381406"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.peptides.2013.08.006","article-title":"The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons","volume":"49","author":"Romano","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0265","doi-asserted-by":"crossref","unstructured":"Romano, A., Pace, L., Tempesta, B., Lavecchia, A.M., Macheda, T., Bedse, G., Petrella, A., Cifani, C., Serviddio, G., Vendemiale, G., Gaetani, S., Cassano, T., 2014. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease. Int. J. Neuropsychopharmacol. 18(4). pii: pyu020. doi: https:\/\/doi.org\/10.1093\/ijnp\/pyu020.","DOI":"10.1093\/ijnp\/pyu020"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phrs.2017.05.017","article-title":"Role of the area postrema in the hypophagic effects of oleoylethanolamide","volume":"122","author":"Romano","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.expneurol.2018.09.011_bb0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2018.09.011_bb0280","doi-asserted-by":"crossref","unstructured":"Scuderi, C., Bronzuoli, M.R., Facchinetti, R., Pace, L., Ferraro, L., Broad, K.D., Serviddio, G., Bellanti, F., Palombelli, G., Carpinelli, G., Canese, R., Gaetani, S., Steardo, L. Jr, Steardo, L., Cassano, T., 2018. Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects. Transl. Psychiatry 8(1): 32. doi: https:\/\/doi.org\/10.1038\/s41398-017-0076-4.","DOI":"10.1038\/s41398-017-0076-4"},{"issue":"5","key":"10.1016\/j.expneurol.2018.09.011_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt90","article-title":"Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies","volume":"3","author":"Shineman","year":"2011","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.expneurol.2018.09.011_bb0290","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11523-011-0174-9","article-title":"Common toxicities of mammalian target of rapamycin inhibitors","volume":"6","author":"Soefje","year":"2011","journal-title":"Target. Oncol."},{"issue":"4","key":"10.1016\/j.expneurol.2018.09.011_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.expneurol.2018.09.011_bb0300","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-6143.2008.02537.x","article-title":"ID2-VEGF-related pathways in the pathogenesis of Kaposi's sarcoma: a link disrupted by rapamycin","volume":"9","author":"Stallone","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.expneurol.2018.09.011_bb0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0166-4328(90)90072-M","article-title":"Hippocampus, amygdala, and memory deficits in rats","volume":"37","author":"Sutherland","year":"1990","journal-title":"Behav. Brain Res."},{"issue":"6967","key":"10.1016\/j.expneurol.2018.09.011_bb0310","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/426620a","article-title":"Genetics: influence of TOR kinase on lifespan in C. elegans","volume":"426","author":"Vellai","year":"2003","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.expneurol.2018.09.011_bb0315","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMoa1403352","article-title":"Response and acquired resistance to everolimus in anaplastic thyroid cancer","volume":"371","author":"Wagle","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.expneurol.2018.09.011_bb0320","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2133\/dmpk.23.469","article-title":"Effect of intestinal and hepatic first-pass extraction on the pharmacokinetics of everolimus in rats","volume":"23","author":"Yokomasu","year":"2008","journal-title":"Drug Metab. Pharmacokinet."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618304898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618304898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T23:36:30Z","timestamp":1542929790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488618304898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":64,"alternative-id":["S0014488618304898"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.09.011","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}